STUDY ON BACTERIAL DISTRIBUTION CHARACTERISTICS AND ANTIBIOTIC RESISTANCE IN PATIENTS WITH COMMUNITY INFECTIONS
Main Article Content
Abstract
Objective: Survey of bacterial characteristics and antibiotic resistance in patients with community-acquired pneumonia (CAP) and community-acquired urinary tract infection (CA-UTI) at Military Hospital 103. Subjects and methods: Cross-sectional descriptive study including 35 patients diagnosed with CAP or CA-UTI admitted to Hospital 103 from December 2024 to April 2025. Clinical data and bacterial culture results were collected. Bacteria were identified and tested for antibiotic resistance using the VITEK 2 system. Results: Mean age 69.4 ± 17.6 years; female: 57.1%. CA-UTI: 68.6%, CAP: 31.4%. Escherichia coli predominated in CA-UTI (66.7%, 16/24); in CAP E. coli and Klebsiella pneumoniae each accounted for 27.3%. All strains were multidrug-resistant (MDR). The number of underlying diseases was associated with the level of resistance (β=0.83, p=0.010). Carbapenems were most effective (>77%), Gentamicin ~57%, Cephalosporin ~48–49%. Ciprofloxacin and TMP-SMX were least effective. Conclusion: Gram-negative bacteria predominated in both CAP (81.8%) and CA-UTI (95.8%). Both groups of bacteria had high levels of resistance. More underlying diseases were associated with higher levels of resistance. Carbapenems remained effective against multidrug-resistant strains; some oral antibiotics (fosfomycin, nitrofurantoin) can be considered for uncomplicated UTI.
Article Details
Keywords
Bacterial distribution; antibiotic resistance; community-acquired infections.
References
2. [Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3): 268-281. doi:10.1111/j.1469-0691. 2011.03570.x
3. Airhihenbuwa CO, Tseng TS, Sutton VD, Price L. Global Perspectives on Improving Chronic Disease Prevention and Management in Diverse Settings. Prev Chronic Dis. 2021 Apr 8;18:E33. doi: 10.5888/pcd18.210055. PMID: 33830913; PMCID: PMC8051856.
4. Montoya A, Mody L. Common infections in nursing homes: a review of current issues and challenges. Aging health. 2011;7(6):889-899. doi:10.2217/AHE.11.80.
5. Eshwarappa M, Dosegowda R, Aprameya IV, Khan MW, Kumar PS, Kempegowda P. Clinico-microbiological profile of urinary tract infection in south India. Indian J Nephrol. 2011;21(1):30-36. doi:10.4103/0971-4065.75226.
6. Osman M, Manosuthi W, Kaewkungwal J, et al. Etiology, Clinical Course, and Outcomes of Pneumonia in the Elderly: A Retrospective and Prospective Cohort Study in Thailand. Am J Trop Med Hyg. 2021;104(6):2009-2016. Published 2021 May 3. doi:10.4269/ajtmh.20-1393.
7. Farhan SM, Raafat M, Abourehab MAS, et al. Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa. Antibiotics (Basel). 2021;10(11): 1429. Published 2021 Nov 22. doi:10.3390/ antibiotics10111429.
8. Sheu CC, Chang YT, Lin SY, Chen YH, Hsueh PR. Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options. Front Microbiol. 2019;10:80. Published 2019 Jan 30. doi:10.3389/fmicb. 2019.00080.